Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(15%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_3
1
8%
Ph not_applicable
11
85%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Phase 3Large-scale testing
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(5)
Completed(5)
Terminated(1)
Other(2)

Detailed Status

Completed5
unknown2
Not yet recruiting2
Recruiting2
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (8.3%)
N/A11 (91.7%)

Trials by Status

unknown215%
completed538%
enrolling_by_invitation18%
not_yet_recruiting215%
recruiting215%
terminated18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DEVICE
Total Trials
13